Melhores Linfoma de Hodgkin médicos em Israel - TOP-19 médicos

Chefe do Departamento de Hematologia do Sourasky Medical Center, liderando a equipe do hospital no tratamento do câncer de sangue.

• Mais de 25 anos de experiência como hematologista
• Especialização realizada no prestigiado Ronald O Perelman e Claudia Cohen Centre
• Especializado em cancros do sangue, como o linfoma de Hodgkin
• Licenciado em medicina pela Universidade de Mysore

Realizou centenas de transplantes de células estaminais – o Dr. Ram é especialista em casos complexos que requerem este procedimento avançado no Sourasky Medical Center.

• Certificado em hematologia, oncologia médica e medicina interna
• Autor de mais de 30 artigos científicos e de um capítulo de um livro de medicina
• Concluiu a sua especialização no New York Medical College e no Westchester Medical Center
• Concentrar-se exclusivamente em cancros hematológicos

A Dra. Ronit El Hasid realizou mais de 300 transplantes pediátricos de medula óssea e sangue do cordão umbilical, chefiando o departamento no Hospital Infantil Dana Dwek de Sourasky.

• Especializar-se em oncologia pediátrica com foco em procedimentos de transplante
• Publicar mais de 50 artigos de pesquisa e 40 relatórios de conferências
• Formar-se no City of Hope Hospital em Los Angeles
• Membro das sociedades de hematologia americana e israelense

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

O Dr. Shapira trabalha no departamento de Transplante de Medula Óssea do Sourasky Medical Center – um tratamento fundamental para o linfoma de Hodgkin.

• Especializar-se em transplante de medula óssea desde o seu cargo sénior no hospital Hadassah
• Formar-se em medicina interna no prestigiado centro médico Hadassah
• Licenciar-se pela Universidade Hebraica, uma das melhores faculdades de medicina de Israel

O Dr. Dror Levin é um renomado especialista em hematologia-oncologia pediátrica no Sourasky Medical Center, especializado em distúrbios sanguíneos e câncer ósseo em crianças.

• Diretor do departamento de hematologia e oncologia pediátrica no Sourasky Medical Center
• Concluiu treinamento especializado no Rizzoli Orthopaedic Institute – um líder global em oncologia óssea
• Membro da associação israelense de hemato-oncologia pediátrica ISPHO
• Coordenar o tratamento multidisciplinar para sarcomas infantis

O Dr. Aviv traz 31 anos de experiência dedicada no tratamento de cancros do sangue no renomado Sourasky Medical Center (Ichilov).

• É especialista em onco-hematologia – a área dos cancros do sangue e da medula óssea
• Oferece consultas online para avaliação remota
• A sua longa carreira foi desenvolvida num dos principais centros médicos de Israel

O Dr. Herishanu Yair recebeu vários prêmios de prestígio por sua pesquisa em hematologia e excelência clínica no Tel-Aviv Sourasky Medical Center.

• Especializar-se no tratamento da leucemia linfocítica crônica
• Ser o vencedor do Prêmio Klitzberg de Oncologia
• Ser membro das associações de hematologia israelense e americana
• Realizar treinamento extensivo em hematologia nos principais centros médicos israelenses

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg é um onco-hematologista especializado em cancros do sangue no Centro Médico Assuta.

• Concentrar-se exclusivamente no tratamento de doenças do sangue e cancros
• Ser especialista nos tratamentos mais recentes para condições como o linfoma de Hodgkin
• Fornecer planos de tratamento personalizados para doenças sanguíneas complexas

A Professora Zila Zuckerman é especialista em hematologia e transplantologia no Rambam Medical Center.

• Especialista no tratamento de cancros do sangue, incluindo o linfoma de Hodgkin
• Foco em técnicas avançadas de transplante
• Trabalha num dos principais centros médicos de Israel

Especializada em radioterapia e oncologia, a Dra. Karen Drumea oferece atendimento especializado no Rambam Medical Center.

• Focar em planos de tratamento personalizados para linfoma de Hodgkin
• Possuir vasta experiência em técnicas de radioterapia
• Ser afiliada ao Rambam Medical Center – uma instituição de saúde líder

Especialista em hematologia com foco em linfomas, incluindo o linfoma de Hodgkin, no Rambam Medical Center.

• Experiência no tratamento de casos de linfoma de Hodgkin
• Especializado em hematologia com foco em doenças linfoproliferativas
• Associado ao Rambam Medical Center, um hospital líder em Israel